https://orcid.org/0000-0001-9993-6439
References
- Escobar-Morreale HF, Sanchon R, San Millan JL. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab. 2008;93:527–533. https://doi.org/10.1210/jc.2007-2053
- Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440–1447. https://doi.org/10.1210/jcem-21-11-1440
- Martin KA, Chang RJ, Ehrmann DA, et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:1105–1120. https://doi.org/10.1210/jc.2007-2437
- Brojeni NR, Salehian B. Androgen secreting ovarian tumors. MOJ Womens Health. 2017;5(6):00145.
- O’Driscoll JB, Mamtora H, Higginson J, et al. A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clin Endocrinol (Oxf). 1994;41:231–236. https://doi.org/10.1111/j.1365-2265.1994.tb02535.x
- Rothman MS, Wierman ME. How should postmenopausal androgen excess be evaluated? Clin. Endocrinol. (Oxf). 2011 Aug;75(2):160–164. https://doi.org/10.1111/j.1365-2265.2011.04040.x
- Wang PH, Chao HT, Lee RC, et al. Steroid cell tumors of the ovary: clinical, ultrasonic, and MRI diagnosis—a case report. Eur J Radiol. 1998 Feb 1;26(3):269–273. https://doi.org/10.1016/S0720-048X(96)01133-3
- Ibanez L, Hall JE, Potau N, et al. Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing. J Clin Endocrinol Metab. 1996 Nov 1;81(11):4103–4107.
- Yance VR, Marcondes JA, Rocha MP, et al. Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies. Eur J Endocrinol. 2017 Jul 1;177(1):93–102. https://doi.org/10.1530/EJE-17-0111
- Sood N, Desai K, Chindris AM, et al. Symptomatic ovarian steroid cell tumor not otherwise specified in a post-menopausal woman. Rare Tumors. 2016 Jun 28;8(2):69–72. https://doi.org/10.4081/rt.2016.6200
- Hayes MC, Scully RE. Ovarian steroid cell tumors (not otherwise specified). A clinicopathological analysis of 63 cases. Am J Surg Pathol. 1987 Nov;11(11):835–845. https://doi.org/10.1097/00000478-198711000-00002
- Mamoojee Y, Ganguri M, Taylor N, et al. Clinical case Seminar: postmenopausal androgen excess–challenges in diagnostic work-up and management of ovarian thecosis. Clin. Endocrinol. (Oxf). 2018 Jan;88(1):13–20. https://doi.org/10.1111/cen.13492